Among active 13F managers last quarter, 9 opened and 1 added, while none reduced or exited; the largest holder to move was Ikarian Capital, LLC (new position). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
14 tracked 13F filers disclose a position in QNCX as of the latest SEC 13F filings, a combined $3.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Ikarian Capital, LLC | 72K | $1.3M | ▲New +72K sh | Q2 2026 | |
| 2 | Squadron Capital Management LLC | 40K | $734K | ▲New +40K sh | Q2 2026 | |
| 3 | Shay Capital LLC | 17K | $329K | ▲New +17K sh | Q2 2026 | |
| 4 | Boothbay Fund Management, LLC | 14K | $253K | ▲New +14K sh | Q2 2026 | |
| 5 | Vanguard Capital Management LLC | 12K | $219K | ▲New +12K sh | Q2 2026 | |
| 6 | Advisory Services Network, LLC | 6K | $558 | ▲New +6K sh | Q1 2026 | |
| 7 | Cormorant Asset Management, LP | 5K | $100K | ▲New +5K sh | Q2 2026 | |
| 8 | Vanguard Fiduciary Trust Co | 4K | $66K | ▲New +4K sh | Q2 2026 | |
| 9 | BlackRock, Inc. | 2K | $31K | ▲New +2K sh | Q2 2026 | |
| 10 | Parallel Advisors, LLC | 795 | $81 | ▲+169% Added · +500 sh | Q1 2026 | |
| 11 | Fortitude Family Office, LLC | 40 | $728 | ▲New +40 sh | Q2 2026 | |
| 12 | Steward Partners Investment Advisory, LLC | 1 | $18 | ▲New +1 sh | Q2 2026 | |
| 13 | JDM Financial Group LLC | 1 | $18 | ▲New +1 sh | Q2 2026 | |
| 14 | Westside Investment Management, Inc. | 1 | $18 | ▲New +1 sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 9 funds opened a new position in QNCX and 1 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Cogent Biosciences IncCOGT | 5 funds | $78.5M |
| Amazon.com IncAMZN | 5 funds | $72.7M |
| Nvidia CorpNVDA | 5 funds | $58.9M |
| Vaxcyte IncPCVX | 5 funds | $56.6M |
| Apple IncAAPL | 5 funds | $52.0M |
| Alphabet Inc-CL AGOOGL | 5 funds | $39.1M |
| Advanced Micro DevicesAMD | 5 funds | $30.0M |
| Microsoft CorpMSFT | 5 funds | $24.4M |
| Meta Platforms Inc-Class AMETA | 5 funds | $22.2M |
| Micron Technology IncMU | 5 funds | $19.8M |
| Taiwan Semiconductor-SP ADRTSM | 5 funds | $17.3M |
| Netflix IncNFLX | 5 funds | $15.8M |
Ranked by how many of QNCX's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in QNCX.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Dec 26, 2025 | Benatti Luca | Director | Sell (S) | 50K | $174K |
| Aug 30, 2024 | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER, Director | Buy (P) | 77K | $54K |
| Aug 29, 2024 | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER, Director | Buy (P) | 78K | $53K |
| Aug 21, 2024 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy (P) 3 lots, same day | 31K | $19K |
| Aug 20, 2024 | Ryan Charles S. | PRESIDENT | Buy (P) | 48K | $31K |
| Aug 20, 2024 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy (P) 2 lots, same day | 6K | $4K |
| Aug 19, 2024 | Hannah Brendan | CHIEF BUSINESS OFFICER AND COO | Buy (P) | 2K | $1K |
| Dec 14, 2023 | Lamond David | Director | Buy (P) | 23K | $24K |
| Dec 13, 2023 | Lamond David | Director | Buy (P) | 23K | $23K |
| Dec 12, 2023 | Lamond David | Director | Buy (P) 2 lots, same day | 23K | $23K |
| Dec 7, 2023 | Lamond David | Director | Buy (P) | 19K | $19K |
| Dec 6, 2023 | Lamond David | Director | Buy (P) | 19K | $20K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 1 | 0 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
| Class | 13F holders | Value held |
|---|---|---|
| 22053A107Equity | 19 funds | $316K |
| QNCXthis pageStock | 12 funds | $3.0M |
| QNCXthis pageStock | 2 funds | $639 |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for QNCX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/QNCX/capital-change-brief"
Use Arkolith's capital_change_brief for QNCX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for QNCX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.